From Lab to Life: How Cardiac Biomarkers are Transforming Diagnosis and Prognosis
October 17, 2025 - 10:00 BST / 11:00 CEST / 20:00 AEDT
Cardiac biomarkers are a vital bridge between the clinical laboratory and real-world clinical impact. This educational webinar will explore how high-sensitivity troponin and natriuretic peptides are revolutionizing the diagnosis and management of cardiovascular disease.
Join Dr. Louise Cullen, Professor of Medicine and Emergency Physician along with Dr. James Januzzi, Professor of Medicine at Harvard Medical School and Chief Scientific Officer of the Baim Institute as they examine how immunoassay technologies are enabling faster and more accurate diagnosis, and more personalized care.
They will discuss the use of high-sensitivity troponin for rapid diagnosis of acute myocardial infarction (AMI) as well as how it could be used as a tool for risk stratification after cardiac presentation to the Emergency Department (ED), including for those not diagnosed at that time with an AMI.
Additionally, they will highlight the benefits of using natriuretic peptides for heart failure diagnosis in the ED and outpatient settings, outlining when to use BNP or NT-proBNP to support diagnosis and ongoing cardiac care.
Designed for lab professionals and clinicians, this webinar will spotlight the critical role of laboratory diagnostics in transforming cardiac care worldwide.
Key learning objectives:
- Identify possible ways to support patient populations that have signs and symptoms of acute coronary syndrome (ACS) and elevated troponin levels but have been ruled out for AMI.
- Identify the key challenges of employing a rapid rule-out algorithm and how to overcome them.
- Understand when and how to use NT-proBNP or BNP for heart failure diagnosis in the ED and outpatient settings.
Who should attend?
Healthcare professionals, cardiologists, clinical staff, lab technicians, lab directors, laboratorians, pathologists, researchers, and academics.
Speakers
Dr. Louise Cullen is a Pre-Eminent Staff Specialist in Emergency Medicine, and a clinical trialist and outcomes researcher in acute diseases. She is enthusiastically involved in the translation of research by clinical redesign and innovation. As an accomplished acute disease researcher, Prof Cullen has focused on the diagnosis and management of patients presenting with possible acute coronary syndromes (ACS) in the emergency department (ED). She has been engaged in many international collaborations and has authored over 300 publications in peer-reviewed journals focused on strategies to improve efficiency whilst maintaining safety for patients with possible ACS, syncope, heart failure, shortness of breath and atrial fibrillation.
Dr. James Januzzi is the Adolph Hutter Professor of Medicine at Harvard Medical School, a staff cardiologist at the Massachusetts General Hospital, and the Chief Scientific Officer and C. Michael Gibson Chair at the Baim Institute for Clinical Research. He is a clinical trialist focused on optimizing diagnosis and treatment of cardiovascular diseases including heart failure and coronary artery disease. His work established the natriuretic peptides as the gold standard diagnostic biomarker for heart failure and is featured in clinical practice guidelines globally. He has published nearly 1,000 manuscripts and his work has been cited nearly 150,000 times.
Moderator
